Core Viewpoint - The announcement details the release of share pledges by the controlling shareholder of Zhejiang Sitaili Pharmaceutical Co., Ltd., indicating a positive development in the company's financial stability and shareholder confidence [1]. Group 1: Share Pledge Release - The controlling shareholder, Mr. Hu Jian, has released 43,176,800 shares, accounting for 9.85% of the company's total share capital and 93.24% of his held shares [1]. - As of the announcement date, the total shares held by Mr. Hu Jian, Mr. Hu Jinsheng, and their concerted parties amount to 97,926,256 shares, representing 22.3367% of the total share capital [1]. - After the release of the pledge, the total number of pledged shares is 46,720,000, which constitutes 47.71% of their held shares [1]. Group 2: Current Pledge Situation - Mr. Hu Jian has 3,123,200 shares remaining pledged, which is 6.74% of his holdings and 0.71% of the company's total share capital [1]. - The controlling shareholders have repaid a total of 198.5575 million yuan in pledge financing since July 2024, significantly reducing their financing balance and pledge ratio [2]. - There are no current risks of share freezing or forced liquidation, and the pledge is not expected to impact the company's control stability or operational management [3].
司太立: 司太立关于控股股东股份质押解除的公告